Eribulin Mesylate Injection
Product Images NDC 43598-125

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 43598-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

Packaging label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution for intravenous use. The label indicates it is a single-dose vial and cautions it as a cytotoxic agent. Distributed by Dr. Reddy's Laboratories Inc., the label includes storage instructions and barcodes, with clear branding and dosage information on multiple panels.*

FDA Label Image

Figure1 (Figure1)

A survival curve graph showing the proportion of patients alive over time (in months) for two groups: Eribulin Mesylate (N=508) and Control (N=254). The graph plots survival rates up to 36 months, with the Eribulin Mesylate group consistently showing a higher survival proportion. A table below the x-axis lists the number of patients at risk over time for both groups.*

FDA Label Image

Figure2 (Figure2)

A survival probability Kaplan-Meier curve comparing Eribulin Mesylate and Dacarbazine. The x-axis shows survival time in months, and the y-axis shows survival probability from 0 to 1. The chart includes a table of subjects at risk over time for each drug.*

FDA Label Image

Structure (Structure)

Chemical structure of Eribulin Mesylate, an active ingredient used in injection formulations. The diagram shows molecular bonds, atoms, and the mesylate group associated with the compound.*

FDA Label Image

Viallabel (Viallabel)

Label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution by Dr. Reddys Laboratories Inc. for intravenous use. It is a single-dose vial labeled as a cytotoxic agent. The label includes storage instructions (20°C to 25°C, do not freeze), barcode, distributor information, and space for lot and expiration date details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.